Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

My journey in the last mile of elimination of leprosy among the Penan community.

Utap M. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia. 2023;
Download PDF
Publication

Slit-skin smear in post kala-azar dermal leishmaniasis and leprosy: How a negative report for Leishman-Donovan bodies in Giemsa stain may indicate leprosy.

Chatterjee K, Yadav V, Ramesh V. JAAD international. 2023;
Download PDF
Publication

A Review of Software and Mobile Apps to Support the Clinical Diagnosis of Hansen Disease.

Costa W, de Oliveira A, Aguilar G, et al. JMIR dermatology. 2023;
Download PDF
Publication

Increased anti-M. Leprae PGL-I igm levels in a child who developed leprosy

Lema T, Bobosha K, Kasang C, et al. Ethiopian Medical Journal. 2023; 60 (3) : 293-295.
Download PDF
Publication

Involvement of Medical Colleges in Implementation of National Strategic Plan 2023-27 for Leprosy Elimination: A Roadmap

Kishore J, Paul B, Roy R. Epidemiology International. 2023; 8 (2) : 4-6.
Download PDF
Publication

Prevalence and risk factors for disability in leprosy patients in Indonesia during the post-elimination era

Samosir PM, Axelia PG, Alkaff FF, et al. PAGEPress Publications. Dermatology Reports. 2023;
Download PDF
Publication

Analysis of misdiagnosed or delayed-diagnosed Leprosy bacillus infection from 1990 to 2020 with a prophet time series prediction in Hubei Province, China

Chen L, Zheng W, Dong X, et al. Ovid Technologies (Wolters Kluwer Health). Medicine. 2023; 102 (32) : 1-7.
Download PDF
Publication

Deep learning for AI-based diagnosis of skin-related neglected tropical diseases: A pilot study.

Yotsu R, Ding Z, Hamm J, et al. PLoS neglected tropical diseases. 2023; 17 (8) : 1-12.
Download PDF
Publication

Non-healing trophic ulcer in leprosy: a case of failure at all levels of prevention.

Reddy H, Joshi A. The Pan African medical journal. 2023;
Download PDF
Publication

COVID-19 vaccination and leprosy-A UK hospital-based retrospective cohort study.

De Barros B, Pierce R, Sprenger C, et al. PLoS neglected tropical diseases. 2023; 17 (8) : 1-11.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 143
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD